I am convinced that Danaher Corporation (NYSE: DHR ) shares are undervalued by the market and are capable of showing growth. The company demonstrates stable growth due to demand for the production of biologics (bioprocess), as well as aHi there! I’m Narek, and I’ve been in the investment world for over six years. I started out as an equity analyst at European banks, digging into reports and learning how to spot value in the markets. I’ve worked across sectors — from telecom to industry — and found that behi ...